Evidence map›Paper›PMID 42733421›Full record

ArticleRadiology case reports2026

Hepatic mesenchymal hamartoma showing hepatobiliary-phase signal increase on gadoxetate disodium-enhanced magnetic resonance imaging: A case report.

Tsubasa Sugie, Nanae Tsuchiya, Shota Kinjo, Masaaki Kuda, Kennosuke Karube, Kazunari Arakaki, Satoru Hamada, Tokiko Oshiro, Shinobu Kiyuna, Mitsuhisa Takatsuki and 1 more

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Radiology case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Tsubasa SugieDepartment of Radiology, Graduate School of Medicine, University of the Ryukyus, Okinawa, Japan.
Nanae TsuchiyaDepartment of Radiology, Graduate School of Medicine, University of the Ryukyus, Okinawa, Japan.
Shota KinjoDepartment of Radiology, Graduate School of Medicine, University of the Ryukyus, Okinawa, Japan.
Masaaki KudaDepartment of Digestive and General Surgery, Graduate School of Medicine, University of the Ryukyus, Okinawa, Japan.
Kennosuke KarubeDepartment of Pathology and Laboratory Medicine, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Kazunari ArakakiDepartment of Pathology, Ryukyu University Hospital, Okinawa, Japan.
Satoru HamadaDepartment of Child Health and Welfare (Pediatrics), Graduate School of Medicine, University of the Ryukyus, Okinawa, Japan.
Tokiko OshiroDepartment of Child Health and Welfare (Pediatrics), Graduate School of Medicine, University of the Ryukyus, Okinawa, Japan.
Shinobu KiyunaDepartment of Child Health and Welfare (Pediatrics), Graduate School of Medicine, University of the Ryukyus, Okinawa, Japan.
Mitsuhisa TakatsukiDepartment of Digestive and General Surgery, Graduate School of Medicine, University of the Ryukyus, Okinawa, Japan.
Akihiro NishieDepartment of Radiology, Graduate School of Medicine, University of the Ryukyus, Okinawa, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We report a case of a 9-month-old girl with mesenchymal hamartoma that was evaluated using gadoxetate disodium-enhanced magnetic resonance imaging. Imaging revealed a large hepatic mass with mixed cystic and solid components, with a slight signal increase in the solid component during the hepatobiliary phase. Histopathology confirmed mesenchymal hamartoma, with normal hepatic parenchyma reticularly interspersed within the mass. Immunohistochemical staining for organic anion transporting polypeptide 1B3 showed cytoplasmic immunoreactivity without membranous staining in hepatocyte-like cells. Mesenchymal hamartoma is a rare benign liver tumor in children, accounting for approximately 8% of all pediatric hepatic tumors. This case suggests that mesenchymal hamartoma may show a slight hepatobiliary-phase signal increase, potentially reflecting delayed contrast retention within the interstitium of the solid component.

Indexed as

Gadoxetate disodiumHepatic mesenchymal hamartomaHepatobiliary phaseOrganic anion transporting polypeptide 1B3Pediatric liver tumor

Identifiers

PMID42733421
PMCPMC13571136

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.